Navigation Links
Valoya Adds Further LED Products to Its Light Solution for Controlled Growing Environments
Date:8/31/2014

(PRWEB) September 01, 2014

Available spectra is similar for all L-series products covering lighting needs for research and cultivation of a wide range of plants. The spectra is enabled by Valoya’s proprietary LEDs with proven patented and pending wide spectrum technology. The single chip spectrum ensures uncompromised light uniformity in critical applications in contrast to growth spectra made from monochromatic and white LEDs.

“Our customers have a large variety of differently sized and shaped growing environments. The expansion of the L-product line increases our ability to provide our light efficiently to any of our customers growing environments, regardless of shelf length or width,” says Sales Director Rabbe Ringbom.

Valoya wide spectrum LED lights have been available in the tube format already for four years, providing benefits such as energy savings, improved growth and better quality. The tube lights high performance at lower wattage per area compared to traditional light sources also reduces cooling needs. The very long lifespan compared to competitor products offers excellent cost of ownership.

The new 900mm LED tube light starts shipping in volume as of September 1st.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12131953.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical
2. Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify
3. JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards
4. ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine
5. NW Bios Patent Portfolio Further Expanded With Manufacturing Automation Patent
6. Further Evidence that the PhotoActivation of PRP (PAPRP) is a Novel and Effective Treatment for Osteoarthritis and Knee Pain
7. Going a step Further: Phase IV and Post-Marketing Observational Studies add Value to new Therapies, life Science Webinar Hosted by Xtalks
8. Prova Education Hires Oncology Expert Alana Brody to Further Expand its Oncology Education and Opportunities
9. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
10. Medifirst Solutions, Inc. Announces Further Update To Shareholders
11. Probiotic Action Announces Further Exploration of Probiotics for Acne with New Information from the LA Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec. 2, 2016 More than $4.3 million was ... Medals dinner ( DHMD ). The gala was held at the ... York City and honored Alan Alda ... to health and medicine and the public understanding of science. ... 2006, the event has raised $40 million for the Laboratory,s ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the ... and a beautiful technology experience. All three tenets were on display at the 2nd ... leaders from over 40 sponsor, CRO and site organizations to discuss innovation and the ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
Breaking Biology Technology:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):